Polish integrated biopharmaceutical company at Kiełpin near Warsaw, founded in 2002 and listed on the Warsaw stock exchange. Makes and sells generic and hybrid medicines, in particular inhaled products for asthma and chronic obstructive pulmonary disease made with its own dry powder inhaler technology, and runs its own research and development in small molecules and biologics with programmes in psychiatry, neurology, metabolic disease and oncology, together with its own manufacturing and laboratories.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét